RxDoctor Payments Data

Zachary Halsey, DO

Family Medicine · Daniels, WVNPI 1780099655

Payments from drug & device makers

$200in general payments, 2019–2025

Across 11 payments — averaging $18.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$57
  • Exact Sciences$28
  • AstraZeneca$21
  • GSK$18
  • AbbVie$16
  • Pfizer$16
  • plus $43 from 3 others

What the payments were for

  • Food & beverage$200100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
21
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$200 in reported general payments places this provider in the 40th percentile of 843 family medicine providers in West Virginia.

See all family medicine providers in West Virginia

Medicare billing

Part B allowed, 2024
$22,143
Medicare patients
356
Services billed
1,994

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide143$157,208
EliquisApixaban126$93,067
JanuviaSitagliptin Phosphate54$73,862
JardianceEmpagliflozin48$65,573
XareltoRivaroxaban38$50,976
EntrestoSacubitril/Valsartan34$28,168
LinzessLinaclotide29$23,337
TrulicityDulaglutide20$21,229
Lantus SolostarInsulin Glargine,hum.Rec.Anlog95$21,227
MounjaroTirzepatide15$21,041
BrilintaTicagrelor25$20,194
TradjentaLinagliptin16$18,789
FarxigaDapagliflozin Propanediol20$18,546
Trelegy ElliptaFluticasone/Umeclidin/Vilanter16$14,154
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog22$14,062

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$57$157,208143 claims
PfizerEliquis, Paxlovid$16$95,925138 claims
AstraZenecaBrilinta, Farxiga, Symbicort$21$49,49577 claims
Lilly USA, LLCTrulicity, Mounjaro$14$42,27035 claims
AbbVieLinzess, Synthroid$16$26,25258 claims
GSKTrelegy Ellipta$18$14,15416 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 40th percentile of 843 family medicine providers in West Virginia.

Other family medicine in Daniels

See the full list for West Virginia

Where these figures come from

Is this you, or does something look wrong? →